Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine

Por Hertel, Peter, Nomikos, George G, Svensson, Torgny H
Publicado em 1997

Lack of Effect of Vortioxetine on the Pharmacokinetics and Pharmacodynamics of Ethanol, Diazepam, and Lithium

Por Chen, Grace, Nomikos, George G., Affinito, John, Zhao, Zhen
Publicado no Clin Pharmacokinet (2016)

Adolescent Female Cannabinoid Exposure Diminishes the Reward-Facilitating Effects of Δ(9)-Tetrahydrocannabinol and d-Amphetamine in the Adult Male Offspring

Por Pitsilis, George, Spyridakos, Dimitrios, Nomikos, George G., Panagis, George
Publicado no Front Pharmacol (2017)

Behavioral and Neurochemical Changes in Mesostriatal Dopaminergic Regions of the Rat after Chronic Administration of the Cannabinoid Receptor Agonist WIN55,212-2

Por Fanarioti, Eleni, Mavrikaki, Maria, Panagis, George, Mitsacos, Ada, Nomikos, George G., Giompres, Panagiotis
Publicado no Int J Neuropsychopharmacol (2015)

DARPP-32 mediates serotonergic neurotransmission in the forebrain

Por Svenningsson, Per, Tzavara, Eleni T., Liu, Feng, Fienberg, Allen A., Nomikos, George G., Greengard, Paul
Publicado em 2002

Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)

Por Svenningsson, Per, Tzavara, Eleni T., Witkin, Jeffrey M., Fienberg, Allen A., Nomikos, George G., Greengard, Paul
Publicado em 2002

The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies

Por Baldwin, David S, Chrones, Lambros, Florea, Ioana, Nielsen, Rebecca, Nomikos, George G, Palo, William, Reines, Elin
Publicado no J Psychopharmacol (2016)

Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats

Por Delis, Foteini, Polissidis, Alexia, Poulia, Nafsika, Justinova, Zuzana, Nomikos, George G., Goldberg, Steven R., Antoniou, Katerina
Publicado no Int J Neuropsychopharmacol (2016)

Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-Aβ antibody

Por Bales, Kelly R., Tzavara, Eleni T., Wu, Su, Wade, Mark R., Bymaster, Frank P., Paul, Steven M., Nomikos, George G.
Publicado em 2006

The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

Por Tzavara, Eleni T, Davis, Richard J, Perry, Kenneth W, Li, Xia, Salhoff, Craig, Bymaster, Frank P, Witkin, Jeffrey M, Nomikos, George G
Publicado em 2003